1. A pilot interventional study to evaluate the impact of cholecalciferol treatment on HbA1c in type 1 diabetes (T1D). Issue 4 (May 2017) Authors: Perchard, R; Magee, L; Whatmore, A; Ivison, F; Murray, P; Stevens, A; Mughal, M Z; Ehtisham, S; Campbell, J; Ainsworth, S; Marshall, M; Bone, M; Doughty, I; Clayton, P E Journal: Endocrine connections Issue: Volume 6:Issue 4(2017) Page Start: 225 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. G460(P) Treatment with a single bolus dose of cholecalciferol does not improve HBA1C levels in a cohort of paediatric patients with type one diabetes. (27th April 2016) Authors: Perchard, R; Magee, L; Mughal, Z; Ehtisham, S; Campbell, J; Ainsworth, S; Marshall, M; Bone, M; Doughty, I; Whatmore, A; Stevens, A; Clayton, PE Journal: Archives of disease in childhood Issue: Volume 101(2016)Supplement 1 Page Start: A274 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Islet autoantibody status in a multi-ethnic UK clinic cohort of children presenting with diabetes. Issue 4 (19th November 2014) Authors: Perchard, R; MacDonald, D; Say, J; Pitts, J; Pye, S; Allgrove, J; Banerjee, K; Amin, R Journal: Archives of disease in childhood Issue: Volume 100:Issue 4(2015) Page Start: 348 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗